Intrinsic Value of S&P & Nasdaq Contact Us

Universal Health Realty Income Trust UHT NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
$55.65
+29.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Universal Health Realty Income Trust (UHT) trades at a trailing P/E of 33.3, forward P/E of 24.9. Trailing earnings yield is 3.01%, forward earnings yield 4.01%. PEG 0.69 (Peter Lynch undervalued ≤1.0). Graham Number is $17.78.

Criteria proven by this page:

  • VALUE (21/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Forward P/E 24.9 (down from trailing 33.3) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.69 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 3.01% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.01% as earnings recover.

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
21/100
Price-to-Earnings & upside
Proven by this page
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
6/100
→ Income
GROWTH
30/100
→ Income
INCOME
70/100
→ Income

Valuation Snapshot — UHT

Valuation Multiples
P/E (TTM)33.3
Forward P/E24.9
PEG Ratio0.69
Forward PEG0.69
P/B Ratio3.84
P/S Ratio3.95
EV/EBITDA14.9
Per Share Data
EPS (TTM)$1.27
Forward EPS (Est.)$1.73
Book Value / Share$11.03
Revenue / Share$10.76
FCF / Share$3.59
Yields & Fair Value
Earnings Yield3.01%
Forward Earnings Yield4.01%
Dividend Yield7.01%
Graham Number$17.78
SharesGrow IV$55.65 (+29.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 51.3 -1.83 4.62 13.16 3.98%
2017 22.4 0.14 4.86 14.15 3.52%
2018 34.8 -0.73 4.24 11.05 4.37%
2019 85.0 -3.94 8.87 20.89 2.32%
2020 45.4 15.67 5.55 11.32 4.30%
2021 7.5 0.02 3.48 9.72 4.71%
2022 31.1 -0.39 2.87 7.25 5.96%
2023 38.7 -1.44 2.97 6.24 6.67%
2024 26.7 1.11 2.86 5.19 7.87%
2025 30.8 -3.56 3.56 5.46 7.57%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.28 $67.08M $17.22M 25.7%
2017 $3.35 $72.35M $45.62M 63.1%
2018 $1.76 $76.21M $24.2M 31.7%
2019 $0.48 $77.16M $6.64M 8.6%
2020 $1.41 $78.01M $19.45M 24.9%
2021 $7.92 $84.19M $109.17M 129.7%
2022 $1.53 $90.63M $21.1M 23.3%
2023 $1.11 $95.58M $15.4M 16.1%
2024 $1.39 $99.01M $19.23M 19.4%
2025 $1.27 $99.19M $17.61M 17.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.73 $1.73 – $1.73 $102.3M $102.3M – $102.3M 1
2027 $1.82 $1.82 – $1.82 $105.4M $105.4M – $105.4M 1
2028 $1.91 $1.91 – $1.91 $112.83M $112.83M – $112.83M 1
2029 $2.01 $2.01 – $2.01 $115.72M $115.72M – $115.72M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message